The Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related Responses

Our objective was to evaluate the immunogenicity of branded and biosimilar infliximab by detecting changes in T-helper-9 (Th9) percentages induced by an in vitro stimulation test. Methods: Peripheral blood mononuclear cells collected from 55 consecutive rheumatoid arthritis (RA) outpatients (15 drug...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Mol Sci
Hlavní autoři: Talotta, Rossella, Berzi, Angela, Doria, Andrea, Batticciotto, Alberto, Ditto, Maria Chiara, Atzeni, Fabiola, Sarzi-Puttini, Piercarlo, Trabattoni, Daria
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5666809/
https://ncbi.nlm.nih.gov/pubmed/29023386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18102127
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky